医疗数据资产流通交易专家

Summary of Medical Data Asset Circulation and Trading Industry Overview - The focus is on the medical data circulation and trading industry in China, particularly in Beijing and Shanghai, with a pilot program initiated by the Beijing Health Commission and Economic and Information Technology Bureau [1][2]. Key Points and Arguments - Pilot Programs and Expansion: In 2023, six municipal hospitals in Beijing began data sharing trials, with plans to expand to 22 hospitals in 2024. Shanghai's Guo'er Hospital will follow in 2025 [2]. - Government Support: The Ministry of Finance's "Pilot Program for Digital Asset Management" emphasizes the management of data assets, including registration, authorization, and revenue distribution [2]. - Market Demand: Major AI companies are actively purchasing medical data to train models, with a notable case of an AI company developing a surgical planning product using data from a chest hospital [2][4]. - High Willingness from Private Institutions: Private medical institutions, including testing centers and specialty hospitals, show a strong willingness to engage in data trading, provided that patient privacy is protected through anonymization [5][6]. - Data Demand Sources: Key demand sources for medical data include AI companies, research institutions, pharmaceutical/device developers, and marketing agencies, with significant interest from leading internet firms [5][6]. - Compliance and Anonymization: Ensuring compliance is critical, requiring patient consent and anonymization of data before external circulation. Third-party data exchanges are used to maintain transparency and legality [7][12]. - CT Imaging Data Demand: There is a strong demand for CT imaging data for model training, with applications categorized into B2B (hospital services) and B2C (individual users) [3][8]. - Challenges in Data Circulation: The industry faces challenges such as varying levels of hospital information technology, lack of internal revenue mechanisms, and the need for technical service providers [11][12]. - Future Market Potential: The medical data circulation and trading industry is expected to grow significantly, driven by increasing hospital digitalization and supportive policies [13][14]. - Cross-Border Data Transactions: There is potential for cross-border data transactions, particularly with foreign pharmaceutical companies interested in purchasing data from Chinese hospitals [15][16]. - Pricing Models: A pricing model for hospital data has been developed in collaboration with Tsinghua University, relying on market references for data valuation [18]. Additional Important Content - Data Standardization: The lack of unified data standards poses a challenge for data integration across hospitals, necessitating the establishment of anonymization protocols and standards [11][12]. - Role of Data Trading Platforms: Platforms like the Beijing Stock Exchange facilitate data circulation by managing transactions and ensuring compliance with regulations [21]. - Inclusion of Rural Data Resources: Smaller hospitals are less likely to provide data but may serve as buyers of AI diagnostic products, indicating a shift in their role within the data ecosystem [22][23].